Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
12,225 people get ARNA articles and Market Currents by email alert.
Get email alerts on ARNA »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
Arena's CEO Discusses Q3 2012 Results - Earnings Call TranscriptTue, Nov 6, 2012 • 10 Comments
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call TranscriptTue, Nov 10, 2009
-
Arena Pharmaceuticals, Inc. Q4 2008 Earnings Call TranscriptFri, Mar 13, 2009
-
Arena Pharmaceuticals, Inc. Q3 2008 Earnings Call TranscriptThu, Oct 30, 2008
-
Arena Pharmaceuticals Inc. Q2 2008 Earnings Call TranscriptTue, Aug 5, 2008
-
Arena Pharmaceuticals, Inc. Q1 2008 Earnings Call TranscriptWed, May 7, 2008 • 1 Comment
-
Arena Pharmaceuticals Q4 2007 Earnings Call TranscriptMon, Mar 10, 2008
-
Arena Pharmaceuticals Q3 2007 Earnings Call TranscriptWed, Oct 17, 2007
-
PR Newswire (May 10, 2013)
-
at CNBC.com (May 2, 2013)
-
PR Newswire (May 2, 2013)
-
at CNBC.com (Apr 11, 2013)
-
PR Newswire (Apr 5, 2013)
-
at MarketWatch.com (Mar 4, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 6, 2013)
-
at CNBC.com (Feb 5, 2013)
-
PR Newswire (Jan 2, 2013)
-
at CNBC.com (Dec 17, 2012)
-
at MarketWatch.com (Dec 14, 2012)
-
PR Newswire (Dec 6, 2012)
-
PR Newswire (Nov 21, 2012)
ARNA vs. ETF Alternatives
Company Description
We are a clinical-stage biopharmaceutical company committed to discovering and developing innovative therapies offering significant medical advances and new options for patients. We are focused on discovering, developing and commercializing oral drugs in four major therapeutic areas:... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, July 9, 2012, 10:56 AM Arena Pharmaceuticals (ARNA +4.3%) rallies with the help of a Sunday Bloomberg column discussing potential M&A interest in the drug developer, thanks to recent FDA approval of its Belviq weight-loss drug. Analysts speculate GlaxoSmithKline (currently divesting a diet pill line) or Japan's Eisai (the U.S. launch partner for Belviq) could make a bid. 25.3% of Arena's float was shorted as of June 15. 6 Comments [Healthcare, On the Move, M&A, Quick Ideas]
-
- View all 2 replies
-
ReaperLynx: I'll wait for another dip below $7.50......maybe $7.75 to add more. -
-
Day Trader001
Looks like $ARNA 's management strategy is still paying off , versus, VVUS "lack of strategy" rush to market! - View all 2 replies
-
-
Day Trader001: LOL....I believe ARNA is the Tortise here!! VVUS is now following ARNA's act.......
-
- View all 2 replies
-
-
dinoyc: I think they are both positioned to do well. Market is broad and it's only 2 players specially if they keep expanding around world.
-
The Wall Street Transcript
Arena Pharmaceuticals' ($ARNA) Weight-Loss Drug Approved by FDA; 3% Weight Loss Recorded- http://su.pr/29wRUI - View all 2 replies
-
-
-
- View all 2 replies
-
-
oneotherfool: Agreed. I had a bid ready in high 6s if it dipped on the open...I canceled it. I won't buy more at this point. Back to the waiting game :)
-
Day Trader001
I believe the Withdraw for European Application of Belviq is an intelligent tactical move by $ARNA! Better than being denied like others. - View all 6 replies
-
-
Day Trader001: Hi Phe, good article, I don't know where ya got the other stuff are you talking about VVUS?
-
Iamstockgeniusjustaskme
$ARNA isn't withdrawing the application similar to saying they were going to be rejected? - View all 2 replies
-
-
Iamstockgeniusjustaskme: $ARNA Thanks I think being in Mensa helped but also I like to thank my parents for their contribution in helping me get to this level.
LATEST REPLIES
-
- View all 2 replies
-
ReaperLynx: I'll wait for another dip below $7.50......maybe $7.75 to add more. -
-
Day Trader001
Looks like $ARNA 's management strategy is still paying off , versus, VVUS "lack of strategy" rush to market! - View all 2 replies
-
-
Day Trader001: LOL....I believe ARNA is the Tortise here!! VVUS is now following ARNA's act.......
-
- View all 2 replies
-
-
dinoyc: I think they are both positioned to do well. Market is broad and it's only 2 players specially if they keep expanding around world.
-
Day Trader001
I believe the Withdraw for European Application of Belviq is an intelligent tactical move by $ARNA! Better than being denied like others. - View all 6 replies
-
-
Day Trader001: Hi Phe, good article, I don't know where ya got the other stuff are you talking about VVUS?
-
The Wall Street Transcript
Arena Pharmaceuticals' ($ARNA) Weight-Loss Drug Approved by FDA; 3% Weight Loss Recorded- http://su.pr/29wRUI - View all 2 replies
-
-
-
- View all 2 replies
-
-
oneotherfool: Agreed. I had a bid ready in high 6s if it dipped on the open...I canceled it. I won't buy more at this point. Back to the waiting game :)
-
Iamstockgeniusjustaskme
$ARNA isn't withdrawing the application similar to saying they were going to be rejected? - View all 2 replies
-
-
Iamstockgeniusjustaskme: $ARNA Thanks I think being in Mensa helped but also I like to thank my parents for their contribution in helping me get to this level.
-
Day Trader001
Good money to be made this week on the $ARNA bounce once again! This is better than an atm machine. - View all 2 replies
-
-
Day Trader001: "No News" as usual! This is a normal dip. Check out Recognia's chart info on Fidelity! Wow, Great move on BBRY!! good thing ya bailed!
-
- View all 1 replies
-
RSI Raistlin: closed $ARNA calls for .78...yea left some money on the table but in and out im happy with the profit
-
- View all 1 replies
-
Day Trader001: $8.00 has been a good bounce mark, but VVUS reports Monday that could affect the sector.
-
- View all 5 replies
-
Crazysight: Well u can't pick them all. Tthought it would probably keep falling the rest of the week, but the areniacs seem 2 b back with a vengeance. -
Crazysight: What a stock this ARNA is though. Never a dull moment with it!
-
- View all 3 replies
-
JOHNMIKE118: I'm holding tough, am sure it is a double from here within 2 months, as soon as it starts selling , LOOKOUT! -
LEIGHDIST: Got out also saw green took it , don't want another AMRN on my hands
-
- View all 4 replies
-
FortSumter: Anybody tuning in to the Biggest Loser last night could easily see the products potential. Haha. -

